Normalizing the Conversation about Naloxone with the Public
Multidisciplinary expert panel share perspectives on stigmatization and normalization of the conversation about naloxone between clinicians and patients.
New Models of Collaborative Care for Atopic Dermatitis
Reviewing the importance of newer models of collaboration between specialty and primary care for atopic dermatitis and educating patients and caregivers for disease management.
Optimizing Multidisciplinary Care for Atopic Dermatitis
Lawrence F. Eichenfield, MD; Jeffrey M. Bienstock, MD, FAAP; Peter A. Lio, MD; and Elizabeth A. Swanson, MD, discuss the importance of an integrative approach to care for the management of atopic dermatitis.
ACC Expert Consensus Decision Pathway for HF Treatment
Using the ACC Expert Consensus Decision Pathway documents for the optimization of heart failure treatment and managing the increasing complexity of the disease.
Heart Failure Treatment in the Healthcare System
A look into the role of heart failure treatment in health care and the overall provision of optimal medical therapy.
Improving the Accessibility of Naloxone and Potential Impact
Joshua Lynch, DO, EMT-P, FAAEM, FACEP, shares ways to improve naloxone accessibility, and Theresa Mallick-Searle, MS, RN-BC, ANP-BC, discusses stigmatization.
Implementing Protocols, Policies, and Programs to Save Lives
Experts weigh in on protocols, policies, and programs that influence patient safety and address when a conversation should ensue with patients about naloxone.
Comorbidities With Atopic Dermatitis
Elizabeth Swanson, MD, leads the discussion on emerging data on comorbid conditions associated with atopic dermatitis and management in the clinical setting.
Role of Early Treatment and Gaps in Heart Failure Diagnosis
The role of early aggressive treatment in preventing progression of heart failures and the importance of understanding the root cause of disease.
SMA Resources for Physicians and Families
Several spinal muscular atrophy (SMA) resources are suggested to help physicians and families: Cure SMA, SMArt Moves, SMA Standard of Care documents, and the Child Neurology Foundation’s Telehealth Tip Sheet.
Hallmark Signs of SMA in Pediatric Patients
Experts suggest what to look for during a virtual examination during COVID-19 that may suggest a diagnosis of spinal muscular atrophy (SMA). If SMA is suspected, they stress the importance of an evaluation, as soon as possible, with a neurologist.